skip to main content

Content language

Contact us: CRM@email.irandoc.ac.ir

Concept information

... > chemical entity > molecular entity > polyatomic entity > heteroatomic molecular entity > salt > organic salt > pyridinium salt > n(2)-(cyclohexylsulfonyl)-n-[(1r)-1-(piperidin-1-ylcarbonyl)-3-(pyridinium-4-ylamino)propyl]glycinamide
organic heterocyclic compound > organonitrogen heterocyclic compound > pyridines > pyridinium salt > n(2)-(cyclohexylsulfonyl)-n-[(1r)-1-(piperidin-1-ylcarbonyl)-3-(pyridinium-4-ylamino)propyl]glycinamide
organic heterocyclic compound > organic heteromonocyclic compound > pyridines > pyridinium salt > n(2)-(cyclohexylsulfonyl)-n-[(1r)-1-(piperidin-1-ylcarbonyl)-3-(pyridinium-4-ylamino)propyl]glycinamide
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > organonitrogen compound > amino-acid derivative > amino acid amide > n(2)-(cyclohexylsulfonyl)-n-[(1r)-1-(piperidin-1-ylcarbonyl)-3-(pyridinium-4-ylamino)propyl]glycinamide
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > organonitrogen compound > carboxamide > amino acid amide > n(2)-(cyclohexylsulfonyl)-n-[(1r)-1-(piperidin-1-ylcarbonyl)-3-(pyridinium-4-ylamino)propyl]glycinamide
organooxygen compound > carboxamide > amino acid amide > n(2)-(cyclohexylsulfonyl)-n-[(1r)-1-(piperidin-1-ylcarbonyl)-3-(pyridinium-4-ylamino)propyl]glycinamide
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > amide > primary amide > carboxamide > amino acid amide > n(2)-(cyclohexylsulfonyl)-n-[(1r)-1-(piperidin-1-ylcarbonyl)-3-(pyridinium-4-ylamino)propyl]glycinamide
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > chalcogen molecular entity > sulfur molecular entity > organosulfur compound > sulfonamide > n(2)-(cyclohexylsulfonyl)-n-[(1r)-1-(piperidin-1-ylcarbonyl)-3-(pyridinium-4-ylamino)propyl]glycinamide
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > chalcogen molecular entity > sulfur molecular entity > sulfur oxoacid derivative > sulfonic acid derivative > sulfonamide > n(2)-(cyclohexylsulfonyl)-n-[(1r)-1-(piperidin-1-ylcarbonyl)-3-(pyridinium-4-ylamino)propyl]glycinamide
... > chemical entity > molecular entity > polyatomic entity > heteroatomic molecular entity > oxoacid derivative > sulfur oxoacid derivative > sulfonic acid derivative > sulfonamide > n(2)-(cyclohexylsulfonyl)-n-[(1r)-1-(piperidin-1-ylcarbonyl)-3-(pyridinium-4-ylamino)propyl]glycinamide
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > amide > primary amide > sulfonamide > n(2)-(cyclohexylsulfonyl)-n-[(1r)-1-(piperidin-1-ylcarbonyl)-3-(pyridinium-4-ylamino)propyl]glycinamide

Preferred term

n(2)-(cyclohexylsulfonyl)-n-[(1r)-1-(piperidin-1-ylcarbonyl)-3-(pyridinium-4-ylamino)propyl]glycinamide  

Type

  • http://www.irandoc.ac.ir/onto/irandoc-meta/Concept

subset

  • 1_STAR

URI

http://www.irandoc.acir/onto/irandoc/CHEBI:43368

Download this concept: